Maximize Your Impact At Advanced Therapies USA 2025
Advanced Therapies USA 2025, taking place November 18–19, 2025, at the Pennsylvania Convention Center in Philadelphia, brings together decision-makers from across the cell and gene therapy ecosystem. This event is critical for biotech executives, biopharma leaders, regulatory experts, investors, and technology providers shaping the future of advanced therapies.
Attendees are focused on translating scientific progress into commercialization, optimizing manufacturing strategies, and accelerating regulatory pathways. The event fosters discussions around clinical-stage investments, CDMO partnerships, and market access planning. Access to the enriched attendee list means teams can identify executive roles leading budgetary and operational decisions across biotech and life sciences.
By connecting early with participants planning to evaluate platforms, technologies, and vendors ahead of their 2026 pipelines, you can establish meaningful relationships and generate intent-driven demand before the convention even begins.
How Sales, Marketing and Revops Teams Can Use This Attendee List
Advanced Therapies USA attracts stakeholders from early-stage biotech startups to commercial-stage biopharma companies. These attendees are evaluating vendor relationships, regulatory support tools, and tech platforms that can scale with their clinical pipelines. Vendelux’s enriched conference attendee list helps commercial teams identify which contacts are responsible for budgets, platform selection, or operational scale-up.
Use this attendee data to segment by company type—such as CDMO, biotech, venture firm—and align messaging to challenges like CMC strategy, site selection, or regulatory submission readiness. Reach out to prospective partners before the event to get meetings on the calendar with scientific officers, heads of manufacturing, or commercialization leads.
During the event, prompt relevant, high-value conversations with senior-level contacts. Afterward, personalize follow-ups with insights connected to each company’s pipeline stage and focus area. This practical use of the enriched attendee list helps you get more meetings, drive strategic outreach, and build long-term value from conference attendees you meet in Philadelphia.
Timing Is Everything
Advanced Therapies USA 2025 is scheduled for November 18–19, 2025. With budgets and project planning for 2026 well underway by fall, engaging with conference attendees before they arrive is a smart way to get ahead.
Use Vendelux’s data to identify the right accounts and decision-makers this spring and summer for warm outreach and meeting scheduling. By aligning your message to the priorities of high-value attendees ahead of time, your team can enter the event with clear objectives and stronger leads.
What’s Included In The Advanced Therapies USA 2025 Attendee List?
Vendelux provides visibility into the expected attendee list for Advanced Therapies USA 2025 based on organizer data and proprietary predictive insights. Clients can upload a list of their targeted accounts to identify relevant matches within the enriched attendee list.
The data includes each attendee’s first and last name, job title, company name, company website, location including city, state, and country, LinkedIn profile, verified email address, and phone number when available. This information supports event planning, lead scoring, and personalized outreach ahead of the conference.
Where Is Advanced Therapies USA 2025?
The conference will be held at the Pennsylvania Convention Center in Philadelphia, Pennsylvania, United States.
When Is Advanced Therapies USA 2025?
Advanced Therapies USA 2025 is scheduled for November 18–19, 2025.
What Type Of Event Is Advanced Therapies USA 2025?
Advanced Therapies USA 2025 is an industry event focused on the commercialization and manufacturing of cell and gene therapies. The event features keynote sessions, panel discussions, and networking dedicated to regulatory strategy, clinical development, and biomanufacturing scale-up. It is a platform for executive-level discussions and partnership development in the biotech and pharmaceutical sectors.
How Many People Attend Advanced Therapies USA 2025?
The event is expected to bring together more than 900 attendees from over 20 countries. The audience primarily consists of C-suite executives, heads of R&D, clinical operations leaders, and investment professionals, with a strong emphasis on senior-level decision-makers driving the growth of advanced therapy companies.
